Aptahem presenterade den 11 maj sin Q1-rapport, vilken i sig inte innehöll några överraskningar, och...
Modelon remains steadfast in its efforts to enhance the capabilities for cloud scaling in its produc...
Redeye provides an update on Kontigo Care following its Q1 2023 report.
Redeye updates its view on M.O.B.A. Network ahead of its Q1 2023 report due on May 30, 2023.
Home Depot reported its Q1 yesterday and trimmed its full year guidance due to lumber deflation, wea...
Redeye states that the Q1 report was solid, but not great.
Redeye updates its estimates following Surgical Science’s Q1 2023 report, which took our forecasts t...
Decent Q1: ARR in line with ABGSCe, adj. EBITDA weaker '23e-'25e ARR unchanged; 1-7% EBITDA cut on h...
On May 15, 2023, STENOCARE announced that the company intends to carry out a preferential Rights Iss...
IRLAB and MSRD sign agreement to evaluate IRL757 & IRL942 Successful evaluation may lead to collabor...
Zoomability publicerade den 16 maj 2023 bolagets delårsrapport för årets första kvartal och visar på...
Tendo redovisade ingen nettoomsättning och ökad rörelseförlust i det första kvartalet.
CirChem har publicerat sin delårsrapport för första kvartalet 2023 och visar på fortsatta framsteg.
Redeye ser positivt på nattens besked att Kanadas läkemedelsmyndighet, Health Canada, har påbörjat s...
I dag offentliggjorde Angler Gaming sin delårsrapport för kv1 2023.
ARR in line with ABGSCe, adj. EBITDA weaker ~27% ARR growth in Q1 despite negative FX impact Reitera...
Redeye states that Modelon Q1 2023 report was largely in line with our projections, while ARR showed...
Redeye’s short comment on the announced management change.
Redeye comments on Genovis Q1 2023, which delivered a beat on practically all metrics on the back of...
Redeye retains its positive view on Lagercrantz following a Q4 report with 9% organic growth and hea...
